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Enabling patients with asthma to obtain the knowledge, conﬁdence and skills they need in order to assume a major role in the
management of their disease is cost effective. It should be an integral part of any plan for long-term control of asthma. The
modiﬁed Patient Enablement Instrument (mPEI) is an easily administered questionnaire that was adapted in the United Kingdom to
measure patient enablement in asthma, but its applicability in Portugal is not known. Validity and reliability of questionnaires
should be tested before use in settings different from those of the original version. The purpose of this study was to test the
applicability of the mPEI to Portuguese asthma patients after translation and cross-cultural adaptation, and to verify the structural
validity, internal consistency and reproducibility of the instrument. The mPEI was translated to Portuguese and back translated to
English. Its content validity was assessed by a debrieﬁng interview with 10 asthma patients. The translated instrument was then
administered to a random sample of 142 patients with persistent asthma. Structural validity and internal consistency were assessed.
For reproducibility analysis, 86 patients completed the instrument again 7 days later. Item-scale correlations and exploratory factor
analysis were used to assess structural validity. Cronbach’s alpha was used to test internal consistency, and the intra-class
correlation coefﬁcient was used for the analysis of reproducibility. All items of the Portuguese version of the mPEI were found to be
equivalent to the original English version. There were strong item-scale correlations that conﬁrmed construct validity, with a one
component structure and good internal consistency (Cronbach’s alpha40.8) as well as high test–retest reliability (ICC = 0.85). The
mPEI showed sound psychometric properties for the evaluation of enablement in patients with asthma making it a reliable
instrument for use in research and clinical practice in Portugal. Further studies are needed to conﬁrm its responsiveness.
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INTRODUCTION
Assessment of patient enablement may prove to be an important
component of effective asthma care, but it is important to know
about the applicability of existing instruments in different cultural
settings.
Asthma is a chronic respiratory disease affecting 1–18% of the
population.1 In Portugal, the latest estimate of the prevalence of
‘current asthma’ is 6.8%, similar in both men and women,2
whereas the estimate for ‘lifelong asthma’ is between 10.24
and 10.5%.2,3
International1–6 and national7 guidelines recommend the
assessment of asthma control at every visit. The assessment
should include symptom control and the risk of adverse
outcomes, as well as a discussion of treatment issues, including
inhaler technique, adherence, and the presence of adverse effects,
and the management of comorbidities that contribute to the
burden of symptoms and poorer quality of life.1,6
Despite the availability of asthma management guidelines and
asthma therapies of proven efﬁcacy, the majority of patients do
not achieve good asthma control.4,7–9 In Portugal it is estimated
that 43% of patients have uncontrolled asthma,10 similar to results
from recent studies in other countries.9
The reasons for poor asthma control include errors in diagnosis,
smoking, comorbid rhinitis, incorrect choice of inhalers, poor
inhaler technique, individual variation in response to treatment,
patient beliefs and concerns, treatment adherence, increased
exposure to environmental allergens, decreased access to good
care, suboptimal self-management and low socioeconomic
status.4,9–12
Effective asthma management and improved outcomes require
a partnership between the patient and healthcare providers.1,4,8
Appropriate asthma self-management13,14 may be the most
cost-effective way to reduce morbidity and mortality.1,9,15,16 This
includes monitoring symptoms, controlling allergens, adhering to
treatment and adjusting medicines when necessary.15
Enabling the person with asthma to assume a major role
in the management of their disease is cost effective and should
be an integral component of any plan for long-term management
of asthma, in accordance with international and national
recommendations.1,4
The Patient Enablement Instrument (PEI) is a self-administered
questionnaire that was developed in the United Kingdom.17 The
PEI is related to, but different from, measures of satisfaction.17
This is a widely accepted tool that has been validated in many
cross-sectional studies. It has been translated and evaluated in
several countries, including Portugal. It has high internal
consistency and delivers consistent results.18–23
In 2006, the PEI was adapted by Haughney and collaborators for
use in asthma management, creating the modiﬁed PEI (mPEI).24
The mPEI demonstrated similar internal consistency and external
validity to the original.24
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The mPEI has since been used in the United Kingdom
and Portugal.24–26 In a Portuguese study, the instrument was
translated and culturally adapted but no psychometric properties
were assessed, hence the importance of the present study.26
The aim was to adapt the mPEI to Portuguese asthma patients
and ensure it is a valid and reliable instrument. So, the objectives
of this study were to test the applicability of the mPEI to
Portuguese asthma patients after translation and cross-cultural
adaptation, and to verify the structural validity, internal consis-
tency and reproducibility.
RESULTS
Participants
The study included a random sample without replacement of
150 patients, aged 18 years old and over, with a diagnosis of
persistent asthma. Initially a random group of 302 patients were
approached for participation in the study and screened for
exclusion criteria. From this group 80 patients had intermittent
asthma and were not currently under chronic treatment
with inhaler devices, 36 patients were unwilling to participate,
20 patients missed the ﬁrst appointment, 10 patients were
improperly diagnosed, 4 patients had cognitive impairment
and 2 patients were unable to independently complete the
questionnaire. In addition, 8 patients could not be reached (due to
emigration and/or cancelling of telephone accounts). Although
150 patients were eligible for the study, only 142 patients could be
recruited in time to participate in the study, 86 (60.6%) of whom
completed the mPEI in both T1 and T2.
The sample consisted of 65 men and 77 women. The age of the
participants ranged from 19 to 88. The demographic character-
istics of the patients for both T1 and T2 are presented in Table 1.
The mean and s.d. of the mPEI (each item and total scale) at
T1 and T2 are presented in Table 2. The total score of the mPEI at
T1 had a minimum of 0 (1.40% of responses) and a maximum
of 12 (19% of responses). There were no ﬂoor or ceiling effects.
At T2, the total score of the mPEI had a minimum of 0 and a
maximum of 12. Ceiling effect was observed in 24.40% of patients.
There was no ﬂoor effect. The score for each item was signiﬁcantly
correlated with total mPEI score.
The suitability of data for factor analysis was assessed.
Inspection of the correlation matrix revealed the presence of
coefﬁcients of 0.3 and above.
At T1, the KMO value was 0.85 and Bartlett’s Test of Sphericity
reached statistical signiﬁcance (χ2 (15) = 402, P= 0.000), which
meant that the levels of correlation between the items of the
instrument were high enough to perform factor analysis on the
sample. PCA revealed the presence of 1 component with an initial
eigenvalue of 3.68, explaining 61.3% of the variance, which
consisted of all six items of the scale. Factor loadings are
presented in Table 3. An inspection of the scree plot revealed a
clear brake after the ﬁrst component.
At T2, the KMO value was 0.82 and Bartlett’s Test of Sphericity
reached statistical signiﬁcance (χ2 (15) = 295, P= 0.000), so the
levels of correlation between the items of the instrument were
enough to perform factor analysis on the sample. PCA revealed
the presence of 1 component with eigenvalue exceeding 1,
explaining 63.1% of the variance, which consisted of all six items
of the scale. Factor loadings are presented in Table 3. An
inspection of the scree plot revealed a clear brake after the ﬁrst
component.
At T1, Cronbach’s alpha was 0.87, and 0.88 at T2. The values of
item-total correlation were between 0.58 and 0.76, indicating that
the mPEI has good internal consistency (Table 4). The mPEI
revealed high test–retest reliability (ICC = 0.85; conﬁdence interval
95%; 0.78 to 0.90).
DISCUSSION
The purpose of this study was to perform a cross-cultural
adaptation of the mPEI questionnaire to Portuguese and to
examine the psychometric properties of the translated scale in a
sample of Portuguese asthma patients. Careful linguistic transla-
tion is a necessary but not sufﬁcient condition for the application
Table 1. Characteristics of participants at T1 and T2 (7 days later)
Characteristics of
patients
T1a (n=142) T2b (n= 86) P-value
Male/female, n (%) 65 (45.8%)/77
(54.7%)
33 (38.4%)/53
(61.6%)
0.30
Age
Mean± s.d. 49.3± 17.0 years 50.8± 17.1 years 0.52
Skewness (s.e.) − 0.04 (0.20) − 0.15 (0.26)
Kurtosis (s.e.) − 0.99 (0.40) − 0.95 (0.51)
Education level
⩽ 4 years, n (%) 53 (37.3%) 37 (43%) 0.39
6 years, n (%) 9 (6.30%) 5 (5.80%) 0.88
9 years, n (%) 17 (12%) 7 (8.10%) 0.35
11 years, n (%) 6 (4.20%) 3 (3.50%) 0.79
12 years, n (%) 26 (18.3%) 14 (16.3%) 0.70
412 years, n (%) 31 (21.8%) 20 (23.3%) 0.79
aFirst interview.
bSecond interview (7 days after ﬁrst interview).
Table 2. Item and scale descriptives and item-scale correlations of the
Portuguese mPEI at T1 and T2 (7 days later)
mPEI item T1a (N=142) T2b (N= 86)
Mean s.d. Correlation with
total mPEI score
Mean s.d. Correlation
with total mPEI
score
Item 1 1.23 0.71 ρ (140)= 0.77* 1.34 0.68 ρ (84)= 0.84*
Item 2 1.39 0.67 ρ (140)= 0.75* 1.50 0.61 ρ (84)= 0.79*
Item 3 1.43 0.64 ρ (140)= 0.80* 1.50 0.59 ρ (84)= 0.80*
Item 4 1.26 0.68 ρ (140)= 0.83* 1.37 0.60 ρ (84)= 0.79*
Item 5 1.20 0.66 ρ (140)= 0.84* 1.31 0.64 ρ (84)= 0,77*
Item 6 1.33 0.65 ρ (140)= 0.71* 1.41 0.64 ρ (84)= 0.77*
Total 7.85 3.13 8.43 2.98
aFirst interview.
bSecond interview (7 days after ﬁrst interview). *Po0.05.
Table 3. Principal component analysis of the Portuguese mPEI for T1
and T2 (7 days later)
T1a T2b
mPEI Loading
factors
Communalities Loading
factors
Communalities
Item 1 0.85 0.57 0.84 0.71
Item 2 0.83 0.55 0.81 0.66
Item 3 0.81 0.66 0.83 0.68
Item 4 0.76 0.69 0.78 0.62
Item 5 0.75 0.71 0.76 0.58
Item 6 0.71 0.50 0.74 0.54
aFirst interview.
bSecond interview (7 days after ﬁrst interview).
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of a patient-outcome instrument in different population, in a
different culture, speaking a different language. The evaluation
of psychometric properties is fundamental to support its cross-
cultural application.
Main ﬁndings
This study revealed good psychometric properties of the
Portuguese mPEI. The results of the item-scale correlation and
the principal component analyses performed using an exploratory
approach support the internal construct validity of the mPEI as a
measure of only one component—enablement. High correlations
between items and the total score and principal factor
demonstrated the relevance and importance of items.
The internal consistency was good suggesting the items
measure the same construct and indicates that the scale is
sufﬁciently reliable for use as an outcome variable in clinical
research. Moreover, the instrument revealed high test–retest
reliability, an aspect not tested in the original study or since. This is
also supported by the fact that mPEI scores were reproducible
between T1 and T2.14,23
The mean mPEI score in this study was higher than that
previously reported in Portugal.26 There was a tendency for ceiling
effects in T1 and in T2. Over 20% of patients scored the highest
score, which could compromise the sensitivity of the instrument.
However, as only 60.6% of patients participated in the data
collection of T2, this could explain the observation. Patients who
are more motivated and concerned with health issues may have a
higher enablement score.
Interpretation of ﬁndings in relation to previously published work
The Portuguese translation of the mPEI has a good correspon-
dence to the original version, and the structure of the questions is
simple and easily understood.24 The cultural adaptation did not
present any difﬁculties, and the patients could comprehend the
constructs involved.
Strengths and limitations of this study
The responsiveness of the instrument, that is, the change in score
over time in case of a meaningful change, is yet to be evaluated.
Further studies are needed to help to establish it as an appropriate
outcome measure in the long-term management of asthma.
Implications for future research, policy and practice
The assessment of psychometric properties recommends the use
for clinical practice of the Portuguese mPEI version.
Conclusions
In conclusion, the Portuguese mPEI is semantically equivalent to
the original instrument. It presented satisfactory measurement
properties according to cross-cultural validity, reproducibility,
internal consistency and factor analysis. Additional research will
test its responsiveness and deﬁne it as a useful outcome measure
to consider in the long-term management of asthma.
MATERIALS AND METHODS
The methods used to adapt and validate the mPEI included the following:
linguistic and cultural adaptation, construct validity and reliability tests.
A ﬂow chart depicting the processes used to examine the validity of the SQ
is presented in Figure 1. Analyses were performed using Statistical Package
for the Social Sciences (SPSS) software for Macintosh Operative System
Version 22.0 (SPSS, IBM Company, Chicago, IL, USA).
Translation and cultural validity
Permission from the authors of the mPEI was obtained in order to use
and translate it into Portuguese. The translation was developed by
Table 4. Internal consistency of the Portuguese mPEI for T1 and T2 (7 days later)
mPEI T1a T2b ICC CI (95%)
Corrected Item-Total
Correlation
Cronbach's Alpha
if Item Deleted
Corrected Item-Total
Correlation
Cronbach's Alpha
if Item Deleted
ICC Lower Upper
Item 1 0.64 0.86 0.75 0.85 0.67 0.50 0.79
Item 2 0.63 0.86 0.71 0.86 0.63 0.44 0.76
Item 3 0.71 0.84 0.73 0.86 0.78 0.66 0.86
Item 4 0.73 0.84 0.67 0.86 0.78 0.67 0.86
Item 5 0.76 0.84 0.66 0.87 0.77 0.65 0.85
Item 6 0.58 0.87 0.63 0.87 0.69 0.53 0.80
Cronbach’s alpha Cronbach’s alpha ICC Lower Upper
Score 0.87 0.88 0.85 0.76 0.90
Abbreviation: CI, conﬁdence interval.
aFirst interview.
bSecond interview (7 days after ﬁrst interview).
Figure 1. A ﬂow chart depicting the process used for validation and
reliability study of the Portuguese mPEI.
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forward–backward translations from the original English version. There
were two independent translations, produced by two native Portuguese-
speaking translators ﬂuent in English. Both versions were compared by a
panel of six general practitioners and, after consensus the instrument was
prepared in a single document. This consensus version was then translated
back to English, by two native English-speaking general practitioners ﬂuent
in Portuguese, without prior knowledge of the original version. This was
then compared with the original, to ensure conceptual and semantic
equivalence. Cognitive debrieﬁng of the Portuguese version of the mPEI
was performed with 10 asthma patients in order to evaluate the adequacy
of the format and presentation and to assess the clarity and interpretation
of each item and response option. Each item was understood and
correctly interpreted by all patients. A panel consisting of six Family
Physicians agreed that the Portuguese version demonstrated semantic and
grammatical equivalence.
Construct validity
The internal construct validity of the scale was ﬁrst evaluated by
Spearman’s correlation coefﬁcient between the item and the scale score.
An item should be substantially linearly related (ρ⩾ 0.4) to the underlying
concept (total score) being measured.27,28 To verify construct validity, the
factorial design of the Portuguese version of the mPEI was analysed in a
stepwise procedure. At both T1 and T2, two measures were used to assess
sampling adequacy—Kaiser–Meyer–Olkin measure (KMO) and Bartlett’s
test of sphericity. KMO is a measure of sampling adequacy calculated for
both the entire correlation matrix and each variable individually. KMO
values above 0.60 indicate that the sample is adequate for factor
analysis.27,28 Bartlett’s test indicates the strength of the association
between variables. It tests the null hypothesis that there is no association
among the variables, only of each variable with itself. Factor analysis is only
indicated when the null hypothesis is rejected. Assuming adequacy of the
sample, a principal component analysis (PCA) with varimax rotation was
also conducted. The number of factors extracted was determined using the
Kaiser method, i.e., according to initial eigenvalues (retention if41.0) and
the visualisation of the Cattell’s scree plot in order to assess the amount of
variance accounted for by a factor.27,28 All factor loadings (i.e., correlations
of an item with a factor) greater than 0.50 were considered relevant.27,28
Reliability study
The temporal stability of both scales was assessed by test–retest by asking
participants to complete both instruments 7 days after the ﬁrst interview.
The change in mean scores between the test and the retest was evaluated
by the intra-class correlation coefﬁcient (ICC) with values ranging from 0
(no stability) to 1 (perfect stability).27,28 Cronbach’s alpha was used to
examine the internal consistency of the instrument. It was considered that
values 40.70 represent acceptable consistency.27,28 Corrected item-total
correlation of 0.30 or higher was considered acceptable for each item.27,28
Participants
This study was conducted in two Family Health Units (FHU), in Matosinhos,
Portugal during February and March 2015. The sample was randomly
selected without replacement from the local database of 620 asthma
patients. Asthma was classiﬁed as persistent according to the indication for
chronic therapy with inhaled corticosteroids. The sample size was
calculated to assure 20 observations per item.23 Patients with cognitive
impairment, kyphoscoliosis, absence of one lung, lung cancer, pregnancy
and those unable to provide informed consent, or unable to independently
complete the questionnaire were excluded before randomisation.
Randomisation was performed using the number generator tool from
SPSS. First, 10 patients were randomly selected to assess translation and
cultural validation. These patients were later excluded from the
randomisation. Second, 150 patients were randomly selected for interview.
No ﬁnancial compensation was provided for participation. The study was
explained to each patient by telephone. The patients who agreed to
participate were invited to come to the FHU at a time of their choosing for
an interview in order to verify their eligibility to enter the study and to
review the consent form. During the interview, demographic data,
including gender, age and educational level, were collected on a form,
identiﬁed with a unique number to preserve conﬁdentiality. Each patient
was scheduled for a second interview 7 days later (T2), at the FHU, at a
time of their choosing.
Questionnaire: modiﬁed patient enablement instrument
The mPEI is a six-item questionnaire. Each item is scored in a Likert-type
scale from 0 (‘same or less’ or ‘not applicable’) to 2 (‘much better’). There is
a minimum score of 0 and a maximum score of 12. A higher score reﬂects
higher patient enablement. The mPEI has good internal consistency with a
reported Cronbach’s alpha coefﬁcient of 0.92.14 The translated version to
Portuguese may be found in Supplementary Appendix 1.
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